{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T03:21:43Z","timestamp":1788837703788,"version":"build-2803163510"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T00:00:00Z","timestamp":1771804800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T00:00:00Z","timestamp":1771804800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"BlueWind Medical"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urogynecol J"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s00192-026-06538-2","type":"journal-article","created":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T12:25:40Z","timestamp":1771849540000},"page":"2451-2461","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Impact of Revi\u00ae Implantable Tibial Neuromodulation on Quality of Life in Patients with Urgency Urinary Incontinence"],"prefix":"10.1007","volume":"37","author":[{"given":"Suzette E.","family":"Sutherland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P. F. A.","family":"Heesakkers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly L.","family":"Ferrante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger R.","family":"Dmochowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,23]]},"reference":[{"key":"6538_CR1","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/j.eururo.2019.02.038","volume":"75","author":"B Peyronnet","year":"2019","unstructured":"Peyronnet B, Mironska E, Chapple C, Cardozo  L, Oelke  M, Dmochowski R, et al. A comprehensive review of overactive bladder pathophysiology: on the way to tailored treatment. Eur Urol. 2019;75:988\u20131000.","journal-title":"Eur Urol"},{"key":"6538_CR2","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s00404-007-0505-3","volume":"277","author":"MA Farage","year":"2008","unstructured":"Farage MA, Miller KW, Berardesca E, Maibach HI. Psychosocial and societal burden of incontinence in the aged population: a review. Arch Gynecol Obstet. 2008;277:285\u201390.","journal-title":"Arch Gynecol Obstet"},{"key":"6538_CR3","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s00508-011-0013-0","volume":"123","author":"K Elenskaia","year":"2011","unstructured":"Elenskaia K, Haidvogel K, Heidinger C, Doerfler D, Umek W, Hanzal E. The greatest taboo: urinary incontinence as a source of shame and embarrassment. Wien Klin Wochenschr. 2011;123:607\u201310.","journal-title":"Wien Klin Wochenschr"},{"key":"6538_CR4","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1111\/jgs.12408","volume":"61","author":"D Xu","year":"2013","unstructured":"Xu D, Kane RL. Effect of urinary incontinence on older nursing home residents\u2019 self-reported quality of life. J Am Geriatr Soc. 2013;61:1473\u201381.","journal-title":"J Am Geriatr Soc"},{"key":"6538_CR5","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s40520-020-01712-y","volume":"33","author":"D Pizzol","year":"2021","unstructured":"Pizzol D, Demurtas J, Celotto S, Maggi S, Smith L, Angiolelli G, et al. Urinary incontinence and quality of life: a systematic review and meta-analysis. Aging Clin Exp Res. 2021;33:25\u201335.","journal-title":"Aging Clin Exp Res"},{"key":"6538_CR6","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1097\/JU.0000000000000309","volume":"202","author":"DJ Lightner","year":"2019","unstructured":"Lightner DJ, Gomelsky A, Souter L, Vasavada SP. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA\/SUFU guideline amendment 2019. J Urol. 2019;202:558\u201363.","journal-title":"J Urol"},{"key":"6538_CR7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/JU.0000000000003985","volume":"212","author":"AP Cameron","year":"2024","unstructured":"Cameron AP, Chung DE, Dielubanza EJ, Enemchukwu E, Ginsberg DA, Helfand BT, et al. The AUA\/SUFU guideline on the diagnosis and treatment of idiopathic overactive bladder. J Urol. 2024;212:11\u201320.","journal-title":"J Urol"},{"issue":"Suppl 2","key":"6538_CR8","doi-asserted-by":"publisher","first-page":"S467","DOI":"10.1007\/s00192-010-1276-0","volume":"21","author":"PE Van Kerrebroeck","year":"2010","unstructured":"Van Kerrebroeck PE. Advances in the role of sacral nerve neuromodulation in lower urinary tract symptoms. Int Urogynecol J. 2010;21(Suppl 2):S467-74.","journal-title":"Int Urogynecol J"},{"issue":"10","key":"6538_CR9","doi-asserted-by":"publisher","first-page":"180","DOI":"10.3390\/brainsci8100180","volume":"8","author":"H Roy","year":"2018","unstructured":"Roy H, Offiah I, Dua A. Neuromodulation for pelvic and urogenital pain. Brain Sci. 2018;8(10):180. https:\/\/doi.org\/10.3390\/brainsci8100180.","journal-title":"Brain Sci"},{"key":"6538_CR10","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/j.neurom.2022.04.034","volume":"25","author":"AM Sayner","year":"2022","unstructured":"Sayner AM, Rogers F, Tran J, Jovanovic  E, Henningham  L, Nahon  I. Transcutaneous tibial nerve stimulation in the management of overactive bladder: a scoping review. Neuromodulation. 2022;25:1086\u201396.","journal-title":"Neuromodulation"},{"key":"6538_CR11","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1097\/JU.0000000000004328","volume":"213","author":"J Heesakkers","year":"2025","unstructured":"Heesakkers J, Toozs-Hobson P, Sutherland SE, Digesu  A, Amundsen  CL, McCrery RJ, et al. Two-year efficacy and safety outcomes of the pivotal OASIS study using the Revi system for treatment of urgency urinary incontinence. J Urol. 2025;213:323\u201332.","journal-title":"J Urol"},{"key":"6538_CR12","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1002\/nau.25477","volume":"43","author":"J Heesakkers","year":"2024","unstructured":"Heesakkers J, Toozs-Hobson P, Sutherland SE, Digesu A, Amundsen CL, McCrery RJ, et al. A prospective study to assess the effectiveness and safety of the BlueWind System in the treatment of patients diagnosed with urgency urinary incontinence. Neurourol Urodyn. 2024;43:1491\u2013503.","journal-title":"Neurourol Urodyn"},{"key":"6538_CR13","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1111\/j.1464-410X.2005.05785.x","volume":"96","author":"RR Dmochowski","year":"2005","unstructured":"Dmochowski RR, Sanders SW, Appell RA, Nitti VW, Davila GW. Bladder-health diaries: an assessment of 3-day vs 7-day entries. BJU Int. 2005;96:1049\u201354.","journal-title":"BJU Int"},{"key":"6538_CR14","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.juro.2006.03.088","volume":"176","author":"KS Coyne","year":"2006","unstructured":"Coyne KS, Matza LS, Thompson CL, Kopp ZS, Khullar V. Determining the importance of change in the overactive bladder questionnaire. J Urol. 2006;176:627\u201332.","journal-title":"J Urol"},{"key":"6538_CR15","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1023\/A:1016370925601","volume":"11","author":"K Coyne","year":"2002","unstructured":"Coyne K, Revicki D, Hunt T, Corey R, Stewart W, Bentkover J, et al. Psychometric validation of an overactive bladder symptom and health-related quality of life questionnaire: the OAB-q. Qual Life Res. 2002;11:563\u201374.","journal-title":"Qual Life Res"},{"key":"6538_CR16","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.urology.2009.08.019","volume":"75","author":"SL Tennstedt","year":"2010","unstructured":"Tennstedt SL, Chiu GR, Link CL, et al. The effects of severity of urine leakage on quality of life in Hispanic, white, and black men and women: the Boston community health survey. Urology. 2010;75:27\u201333.","journal-title":"Urology"},{"issue":"12","key":"6538_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare11121772","volume":"11","author":"AM AlQuaiz","year":"2023","unstructured":"AlQuaiz AM, Kazi A, AlYousefi N, Alwatban L, AlHabib Y, Turkistani I. Urinary incontinence affects the quality of life and increases psychological distress and low self-esteem. Healthcare Basel. 2023;11(12):1772.","journal-title":"Healthcare Basel"},{"key":"6538_CR18","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.eururo.2006.09.022","volume":"51","author":"B Monz","year":"2007","unstructured":"Monz B, Chartier-Kastler E, Hampel C, Samsioe G, Hunskaar S, Espuna-Pons M, et al. Patient characteristics associated with quality of life in European women seeking treatment for urinary incontinence: results from PURE. Eur Urol. 2007;51:1073\u201381.","journal-title":"Eur Urol"},{"key":"6538_CR19","doi-asserted-by":"publisher","first-page":"459","DOI":"10.7326\/0003-4819-148-6-200803180-00211","volume":"148","author":"TA Shamliyan","year":"2008","unstructured":"Shamliyan TA, Kane RL, Wyman J, Wilt TJ. Systematic review: randomized, controlled trials of nonsurgical treatments for urinary incontinence in women. Ann Intern Med. 2008;148:459\u201373.","journal-title":"Ann Intern Med"},{"key":"6538_CR20","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s12325-024-03019-0","volume":"42","author":"CL Amundsen","year":"2025","unstructured":"Amundsen CL, Sutherland SE, Kielb SJ, Dmochowski RR. Sacral and implantable tibial neuromodulation for the management of overactive bladder: a systematic review and meta-analysis. Adv Ther. 2025;42:10\u201335.","journal-title":"Adv Ther"},{"key":"6538_CR21","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1002\/nau.22266","volume":"32","author":"KM Peters","year":"2013","unstructured":"Peters KM, Carrico DJ, MacDiarmid SA, Wooldridge LS, Khan AU, McCoy CE, et al. Sustained therapeutic effects of percutaneous tibial nerve stimulation: 24-month results of the STEP study. Neurourol Urodyn. 2013;32:24\u20139.","journal-title":"Neurourol Urodyn"}],"container-title":["International Urogynecology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-026-06538-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00192-026-06538-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-026-06538-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:14:18Z","timestamp":1787066058000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00192-026-06538-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,23]]},"references-count":21,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["6538"],"URL":"https:\/\/doi.org\/10.1007\/s00192-026-06538-2","relation":{},"ISSN":["0937-3462","1433-3023"],"issn-type":[{"value":"0937-3462","type":"print"},{"value":"1433-3023","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,23]]},"assertion":[{"value":"15 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Investigational device exemption (IDE) # G200013. ClinicalTrials.gov Identifier: NCT03596671.","order":1,"name":"Ethics","label":"Study Registration","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"J.P.F.A.H., S.E.S., K.L.F., and R.R.D. reported being paid consultants for BlueWind Medical. The authors declare that these relationships have not influenced the design, conduct, or reporting of the study.An employee of BlueWind Medical authored the first draft of this manuscript to ensure protection of commercially valuable intellectual property; this first draft primarily consisted of summarizing the study methods and outcomes. The investigator authors listed above completed the results interpretation and conclusions to ensure that the appropriate scientific rigor was applied and relevant safety concerns were addressed. The investigator authors listed above were compensated for their participation in the study in that all study-related costs were covered by BlueWind Medical; but not for their time writing or reviewing the manuscript.","order":2,"name":"Ethics","label":"Disclosures","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The following  lists all sites and details for Institutional Review Board (IRB) approval to participate in this study:","order":3,"name":"Ethics","label":"IRB Approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}